Improvements in eliciting dose across baseline sensitivities following 12 months of epicutaneous immunotherapy (EPIT) in peanut-allergic children aged 4 to 11 years

Authors :: Todd D. Green
Dianne E. Campbell
Matthew Greenhawt
Romain Lambert
Edwin H. Kim
David Fleischer
Source :: The journal of allergy and clinical immunology. In practice. 8(9)
Publication Year :: 2020

Subjects :: medicine.medical_specialty
Arachis
business.industry
medicine.medical_treatment
Immunotherapy
Allergens
Desensitization, Immunologic
Internal medicine
Child, Preschool
Immunology and Allergy
Medicine
Humans
Peanut Hypersensitivity
Baseline (configuration management)
business
Child

Tools